Table I.
FIGO stage | Patients, n (%) | Age ± SD (years) | Parity ± SD (n) | FM ± SD | LMP ± SD |
---|---|---|---|---|---|
IB | 16 (32.6) | 61.6±10.24 | 2.1±1.09 | 13.9±1.84 | 51.2±3.36 |
IC | 14 (28.6) | 69.1±8.99 | 2.9±2.27 | 14.8±1.75 | 51.3±3.24 |
II | 5 (10.2) | 67.7±4.99 | 2.0±0.82 | 14.5±1.00 | 51.5±2.38 |
III | 5 (10.2) | 52.2±3.77a | 1.2±1.26 | 14.0±0.82 | 50.7±2.22 |
Normal endometrium | 9 (18.4) | 50.1±7.56b | 2.0±1.12 | 14.3±1.66 | 47.6±3.03c |
FM, first menstruation; LMP, last menstrual period.
Statistically significant younger patients with EC in stage III compared to patients at stage IC (p<0.01) and stage II (p<0.01), respectively.
Statistically significant younger patients with normal endometrium compared to patients with EC at stage IB (p<0.01), stage IC (p<0.01) and stage II (p<0.01), respectively.
Statistically significant lower age of LMP in the group with normal endometrium compared to women with EC at stage IB (p<0.04) and stage IC (p<0.04), respectively.